Terms: = Skin cancer AND MITF, WS2A, ENSG00000187098, 4286
797 results:
1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
2. The mitf/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
Liguoro D; Frigerio R; Ortolano A; Sacconi A; Acunzo M; Romano G; Nigita G; Bellei B; Madonna G; Capone M; Ascierto PA; Mancini R; Ciliberto G; Fattore L
Cell Death Dis; 2024 Mar; 15(3):208. PubMed ID: 38472212
[TBL] [Abstract] [Full Text] [Related]
3. Emerging roles of mitf as a crucial regulator of immunity.
Lee A; Lim J; Lim JS
Exp Mol Med; 2024 Feb; 56(2):311-318. PubMed ID: 38351314
[TBL] [Abstract] [Full Text] [Related]
4. Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation.
Mendelson K; Martin TC; Nguyen CB; Hsu M; Xu J; Lang C; Dummer R; Saenger Y; Messina JL; Sondak VK; Desman G; Hasson D; Bernstein E; Parsons RE; Celebi JT
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38319712
[TBL] [Abstract] [Full Text] [Related]
5. DNA damage remodels the mitf interactome to increase melanoma genomic instability.
Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
[TBL] [Abstract] [Full Text] [Related]
6. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
[TBL] [Abstract] [Full Text] [Related]
7. Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.
Monti M; Benerini Gatta L; Bugatti M; Pezzali I; Picinoli S; Manfredi M; Lavazza A; Vanella VV; De Giorgis V; Zanatta L; Missale F; Lonardi S; Zanetti B; Bozzoni G; Cadei M; Abate A; Vergani B; Balzarini P; Battocchio S; Facco C; Turri-Zanoni M; Castelnuovo P; Nicolai P; Fonsatti E; Leone BE; Marengo E; Sigala S; Ronca R; Perego M; Lombardi D; Vermi W
J Transl Med; 2024 Jan; 22(1):35. PubMed ID: 38191367
[TBL] [Abstract] [Full Text] [Related]
8. Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.
Wei C; Sun W; Shen K; Zhong J; Liu W; Gao Z; Xu Y; Wang L; Hu T; Ren M; Li Y; Zhu Y; Zheng S; Zhu M; Luo R; Yang Y; Hou Y; Qi F; Zhou Y; Chen Y; Gu J
Nat Commun; 2023 Dec; 14(1):8119. PubMed ID: 38065972
[TBL] [Abstract] [Full Text] [Related]
9. HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.
Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract] [Full Text] [Related]
11. Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
Berico P; Nogaret M; Cigrang M; Lallement A; Vand-Rajabpour F; Flores-Yanke A; Gambi G; Davidson G; Seno L; Obid J; Vokshi BH; Le Gras S; Mengus G; Ye T; Cordero CF; Dalmasso M; Compe E; Bertolotto C; Hernando E; Davidson I; Coin F
Cell Rep; 2023 Nov; 42(11):113363. PubMed ID: 37924516
[TBL] [Abstract] [Full Text] [Related]
12. Transglutaminase Type 2-mitf axis regulates phenotype switching in skin cutaneous melanoma.
Muccioli S; Brillo V; Varanita T; Rossin F; Zaltron E; Velle A; Alessio G; Angi B; Severin F; Tosi A; D'Eletto M; Occhigrossi L; Falasca L; Checchetto V; Ciaccio R; Fascì A; Chieregato L; Rebelo AP; Giacomello M; Rosato A; Szabò I; Romualdi C; Piacentini M; Leanza L
Cell Death Dis; 2023 Oct; 14(10):704. PubMed ID: 37898636
[TBL] [Abstract] [Full Text] [Related]
13. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
14. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
Linos K
J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
[TBL] [Abstract] [Full Text] [Related]
15. Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells.
Möller JKS; Linowiecka K; Gagat M; Brożyna AA; Foksiński M; Wolnicka-Glubisz A; Pyza E; Reiter RJ; Tulic MK; Slominski AT; Steinbrink K; Kleszczyński K
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834395
[TBL] [Abstract] [Full Text] [Related]
16. Acetylation reprograms mitf target selectivity and residence time.
Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
[TBL] [Abstract] [Full Text] [Related]
17. The C-terminal transactivation domain of mitf interacts promiscuously with co-activator CBP/p300.
Brown AD; Lynch K; Langelaan DN
Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
[TBL] [Abstract] [Full Text] [Related]
18. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity.
Subhadarshini S; Sahoo S; Debnath S; Somarelli JA; Jolly MK
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37678920
[TBL] [Abstract] [Full Text] [Related]
19. GREB1 isoform 4 is specifically transcribed by mitf and required for melanoma proliferation.
Shinzawa K; Matsumoto S; Sada R; Harada A; Saitoh K; Kato K; Ikeda S; Hirayama A; Yokoi K; Tanemura A; Nimura K; Ikawa M; Soga T; Kikuchi A
Oncogene; 2023 Oct; 42(42):3142-3156. PubMed ID: 37658191
[TBL] [Abstract] [Full Text] [Related]
20. Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities.
Logesh R; Prasad SR; Chipurupalli S; Robinson N; Mohankumar SK
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188968. PubMed ID: 37657683
[TBL] [Abstract] [Full Text] [Related]
[Next]
